
Kip Wallen
Senior Director, Thought Leadership
Kip Wallen
Senior Director, Thought Leadership
Kip Wallen is a senior director leading the SRS Acquiom thought leadership practice. He leverages his extensive expertise and SRS Acquiom proprietary data to produce resourceful content regularly utilized by market practitioners. Kip has broad experience in M&A and provides guidance on market standards and trends.
Previously, Kip was a Director with the SRS Acquiom Transactional Group, where he collaborated with clients and counsel to negotiate M&A documents including purchase, escrow, payments, and other transactional agreements. Before joining SRS Acquiom, Kip was an attorney with a Denver-based boutique business law firm where he assisted clients with M&A transactions as well as general corporate governance and securities matters.
Kip is an avid supporter of the Colorado Symphony, serving on the Associate Board and Colorado Symphony Fund Board, and the Colorado Rockies. He is an active participant on the American Bar Association’s M&A Committee. In 2016, Kip completed Leadership 20 with the Denver chapter of the Association for Corporate Growth.
Kip received his J.D. from the Sturm College of Law at the University of Denver and an M.S. in Economics, B.S. in Economics and B.A. in International Relations from Lehigh University. He is a member of the Colorado bar.
Contact Information
kwallen@srsacquiom.com
720.452.5364
Denver, CO
Insights from Kip Wallen
Life Sciences
Life Sciences M&A: Are You Prepared for Post-Closing Challenges?

Shareholder Representation
Tools for Practitioners
M&A Purchase Price Adjustments Are Common Yet Complex

Deal Terms Analysis
Valuation Disconnects Driving a Spike in Earnouts in M&A

Life Sciences
2023 Life Sciences M&A Earnout Achievement: Key Findings by Industry Sector

Deal Terms Analysis
Life Sciences
2023 SRS Acquiom Life Sciences M&A Study

Life Sciences
Life Sciences M&A: Are You Prepared for Post-Closing Challenges?

Shareholder Representation
Tools for Practitioners
M&A Purchase Price Adjustments Are Common Yet Complex

Deal Terms Analysis
Valuation Disconnects Driving a Spike in Earnouts in M&A

Life Sciences
2023 Life Sciences M&A Earnout Achievement: Key Findings by Industry Sector

Deal Terms Analysis
Life Sciences
2023 SRS Acquiom Life Sciences M&A Study